# A Study of Pharmacokinetics, Safety and Tolerability of Dimolegin (DD217)

> **NCT05181241** · PHASE1 · COMPLETED · sponsor: **PharmaDiall Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Dimolegin

## Key facts

- **NCT ID:** NCT05181241
- **Lead sponsor:** PharmaDiall Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-25
- **Primary completion:** 2017-12-25
- **Final completion:** 2018-04-25
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05181241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05181241, "A Study of Pharmacokinetics, Safety and Tolerability of Dimolegin (DD217)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05181241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*